Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.
NutriLeads
Series C in 2023
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Octarine Bio
Series A in 2023
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.
Meatable is a Dutch food production company that specializes in creating cultured meat using stem cell technology. Founded in 2019, the company employs pluripotent stem cells to transform various types of cells into muscle or fat tissue, eliminating the need for animal slaughter. This process enables Meatable to produce sustainable, guilt-free meat without compromising taste and texture.
Incredo, a global food-tech company formerly known as DouxMatok, specializes in developing innovative technologies aimed at reducing sugar consumption while maintaining the sensory qualities of sweetness. Founded in 2014 and headquartered in Petach-Tikva, Israel, Incredo has created a proprietary solution that enhances the sweetness of real cane sugar without the undesirable aftertaste, allowing for a significant reduction in sugar content in various food products. The company's approach ensures that consumers can enjoy their favorite foods and snacks with less sugar, without sacrificing taste, mouthfeel, or texture. This focus on healthier consumption aligns with growing consumer demand for nutritious alternatives in the food industry.
VitaminLab
Series A in 2023
VitaminLab is a biopharmaceutical company focused on delivering personalized vitamins and supplements tailored to individual health needs. By utilizing health histories, nutrient testing, and a proprietary matching algorithm, the company creates customized supplements that aim to enhance overall well-being. Founded by a team of pharmacists and healthcare professionals, VitaminLab emphasizes the use of all-natural ingredients, including beetroot, stevia, and prebiotics, to formulate its products. This innovative approach seeks to transform the supplement industry by providing consumers with solutions that address their unique biological and health profiles.
Athian is a technology-driven company focused on promoting environmental sustainability within animal agriculture. Based in Indianapolis, Indiana, Athian leverages a cloud-based platform to aggregate, verify, and certify greenhouse gas (GHG) reductions across the livestock value chain, specifically targeting the beef and dairy sectors. The company’s mission is to assist livestock producers in capturing and monetizing carbon credits generated through their sustainability efforts. By providing an industry-specific analytics tool, Athian delivers validated GHG reductions to various stakeholders, including consumer packaged goods companies and food retailers, which facilitates funding for producers' sustainability initiatives. Through its innovative approach, Athian aims to enhance the economic and environmental health of farms and their surrounding communities.
Paleo is a food ingredient company focused on developing innovative ingredients for plant-based foods, specifically targeting alternatives to meat and fish. The company utilizes precision fermentation to produce animal-free heme proteins that are GMO-free and replicate the sensory and nutritional properties of their animal-derived counterparts. By leveraging bioscience, Paleo aims to create ingredients that enhance the taste, texture, and appearance of plant-based products, making them more appealing to consumers. This commitment to sustainability allows businesses to offer alternatives that do not harm animals while meeting the growing demand for healthier and environmentally friendly food options.
Meala Foodtech
Pre Seed Round in 2023
Meala is a food technology company focused on developing functional proteins aimed at transforming the plant-based protein sector. The company utilizes naturally occurring biocatalysts to enhance plant-based proteins, creating meat-like textures and juiciness that closely resemble animal-derived products. This innovative approach allows producers to formulate cleaner labels and healthier options with fewer ingredients, catering to the growing demand for plant-based alternatives in the food industry. Through its advancements, Meala seeks to provide effective solutions for meat replacements, positioning itself as a key player in the evolution of sustainable protein sources.
Miach Orthopaedics
Series B in 2023
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, specializing in the development of bio-engineered surgical implants aimed at promoting new tissue growth and aiding in connective tissue repair. Founded in 2016, the company focuses on its innovative Bridge-Enhanced ACL Repair technology, which serves as an alternative to traditional anterior cruciate ligament (ACL) reconstruction. This technology provides surgeons with a method to restore the normal anatomy and function of the knee for patients who have experienced ACL injuries, offering a promising option for recovery and rehabilitation.
Flore by Sun Genomics
Series B in 2022
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Octarine Bio
Seed Round in 2022
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.
Momentous
Series A in 2022
Momentous is a nutritional supplement company based in Palo Alto, California, founded in 2016 by Matt Wan and Rob Dyrdek. The company specializes in performance products tailored for athletes, utilizing insights from experts in professional sports leagues such as the NFL, NBA, and NHL. Momentous emphasizes the use of high-quality, organic, and gluten-free ingredients in its formulations, ensuring that its supplements are clean, safe, and effective. The product line is designed to enhance athletic performance while providing exceptional taste without the use of fillers.
Rootine is a precision health company that focuses on optimizing individual health through personalized nutrition solutions. By leveraging technology and health data, Rootine helps clients understand their unique biological needs and provides tailored recommendations for vitamins and nutrients. The company utilizes precision lab tests and wearable analytics to create a comprehensive health profile for each individual. Rootine's platform includes a dashboard that allows users to track their progress and receive ongoing adjustments to their nutrient regimens as their bodies evolve. This data-driven approach aims to enhance energy, productivity, stress management, and overall health, catering to a diverse range of clients from seasoned athletes to those beginning their health journey.
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.
Chinova Bioworks
Series A in 2022
Chinova Bioworks Inc. is a Canadian company established in 2016, specializing in the development of natural antimicrobials for the beverage industry. Based in Fredericton, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This innovative antimicrobial offers broad-spectrum protection against spoilage, effectively enhancing the shelf life of fresh juices and other products. Chinova's preservative is recognized for being a natural and healthy ingredient, making it suitable for use not only in foods and beverages but also in cosmetics and personal care items. By providing solutions that improve quality and freshness while reducing food waste, Chinova Bioworks aims to increase consumer satisfaction and support manufacturers in their efforts to deliver premium products.
Inne is a Berlin-based biotech startup focused on developing a hormone-based mini lab aimed at providing women with convenient and accurate natural contraception solutions. The company has created an in vitro diagnostic device that analyzes fertility hormones in saliva, allowing users to gain insights into their ovulation, menstrual cycles, and hormone levels. By leveraging biochemistry and a companion app, Inne empowers women to better understand their bodies and make informed decisions regarding their fertility and overall health. This innovative approach seeks to enhance women's ability to track their hormonal changes and accurately identify their fertility phases in a simple and user-friendly manner.
OK Capsule
Seed Round in 2022
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.
ATRO Medical
Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.
OK Capsule
Seed Round in 2021
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.
Rootine
Seed Round in 2021
Rootine is a precision health company that focuses on optimizing individual health through personalized nutrition solutions. By leveraging technology and health data, Rootine helps clients understand their unique biological needs and provides tailored recommendations for vitamins and nutrients. The company utilizes precision lab tests and wearable analytics to create a comprehensive health profile for each individual. Rootine's platform includes a dashboard that allows users to track their progress and receive ongoing adjustments to their nutrient regimens as their bodies evolve. This data-driven approach aims to enhance energy, productivity, stress management, and overall health, catering to a diverse range of clients from seasoned athletes to those beginning their health journey.
Prenexus Health
Series B in 2021
Prenexus Health, Inc. is a manufacturer of natural prebiotic ingredients, specializing in the scientific research, development, and production of components for functional foods, beverages, and dietary supplements. Founded in 2015 and headquartered in Gilbert, Arizona, the company emphasizes digestive health and wellness through its innovative offerings, including XOS95, a highly purified prebiotic ingredient derived from high-fiber sugarcane. Prenexus Health is recognized as a global leader in the prebiotic sector, underpinned by extensive scientific and clinical research that supports its products' efficacy in enhancing digestive and microbiome health. The company serves clients in the fast-moving consumer goods sector, providing them with high-quality functional ingredients to improve their products.
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.
Leading Edge Equipment Technologies
Convertible Note in 2021
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of advanced equipment for solar panel production, specializing in single-crystal silicon wafers. Established in 2008 and based in Wilmington, Massachusetts, the company has developed a kerfless method that significantly reduces the costs associated with producing silicon wafers while increasing the efficiency of solar panels. This innovative process eliminates the need for wire-sawing large silicon ingots and utilizes less energy-intensive furnaces, resulting in higher efficiency solar cells and reduced carbon emissions. By offering a solution that integrates seamlessly into existing manufacturing processes, Leading Edge Equipment Technologies enables solar cell and panel manufacturers to enhance their products' power output without requiring substantial changes to their operations. The company, which rebranded from Leading Edge Crystal Technologies in May 2020, continues to advance technologies that support the growth of sustainable energy solutions.
Brains Bioceutical
Series A in 2021
Brains Bioceutical Corp. is a Canadian company based in Vancouver that specializes in the production of naturally-sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical sectors. The company focuses on cannabidiol (CBD) products, offering a range of formulations including oils, capsules, balms, and sprays. Brains Bioceutical adheres to Good Manufacturing Practices (GMP) standards, ensuring that its products are of high quality and safe for consumers. Its offerings are designed to be tetrahydrocannabinol-free, non-genetically modified, and vegan, catering to diverse markets such as pharmaceutical, health and wellness, skin and beauty, and veterinary industries. By providing affordable, high-quality ingredients, the company aims to support the development of effective wellness products for patients.
Meatable is a Dutch food production company that specializes in creating cultured meat using stem cell technology. Founded in 2019, the company employs pluripotent stem cells to transform various types of cells into muscle or fat tissue, eliminating the need for animal slaughter. This process enables Meatable to produce sustainable, guilt-free meat without compromising taste and texture.
Deep Branch Biotechnology
Series A in 2021
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, United Kingdom, specializes in carbon recycling services aimed at creating sustainable food ingredients. The company employs a proprietary gas fermentation platform that utilizes clean and renewable carbon and energy sources to produce bio-based products for the food and feed markets. By focusing on customer-driven research and development, Deep Branch rapidly delivers high-quality ingredients while collaborating with local providers to ensure sustainable input supplies and support local economies. Its approach includes integrating with carbon dioxide suppliers to deploy its technology efficiently, contributing to a reduction in carbon footprints by up to 60% compared to traditional alternatives. This innovative model allows Deep Branch to create locally-produced ingredients that require no arable land and minimal water, effectively addressing climate change and biodiversity loss while ensuring that consumers do not have to compromise on nutrition or quality.
Novum Medical
Venture Round in 2021
Novum Medical is a developer of innovative orthopedic implants, specializing in resorbable ortho-biomaterials designed for musculoskeletal surgery. The company focuses on creating products that utilize bioactive glass, which possesses porous, load-bearing, and osteoconductive properties. These advanced materials enhance the interface between the implant and bone, promoting a more natural healing process and improving overall performance. Novum Medical's technologies aim to enable surgeons to reconstruct bony anatomy effectively, addressing the clinical limitations associated with existing options in the market. The company's research and development efforts have broad applications within the musculoskeletal system.
Additive Manufacturing Technologies
Series A in 2021
Additive Manufacturing Technologies (AMT) specializes in automated post-processing technology aimed at enhancing the efficiency of additive manufacturing. The company's flagship platform, PostPro, significantly improves cost, quality, safety, and throughput in the production of 3D printed parts. By automating the manual and often expensive steps traditionally associated with legacy additive manufacturing, AMT enables facilities to scale up to high-volume production lines. Their innovative digital technology and comprehensive suite of post-production hardware facilitate the processing of 3D-printed polymer parts, allowing clients to reduce lead times and manufacturing costs effectively.
Frontier Nutrition
Series B in 2021
Frontier Nutrition, Inc. is a company dedicated to developing and manufacturing nutritious food products tailored for families in low and middle-income communities worldwide. Founded in 2016, the company focuses on addressing malnutrition, particularly among mothers and young children, by providing affordable and convenient food options. Their product offerings are based on research in pediatric nutrition and behavioral marketing, ensuring that recipes are not only nutritionally optimized but also appealing in taste and price. By localizing their recipes to fit traditional diets, Frontier Nutrition aims to make a significant impact on public health in frontier markets, where access to healthcare, clean water, and transportation can be limited. The company operates from its base in New Haven, Connecticut, and is committed to fostering sustainable living standards for underserved populations.
Leading Edge Equipment Technologies
Series A in 2020
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of advanced equipment for solar panel production, specializing in single-crystal silicon wafers. Established in 2008 and based in Wilmington, Massachusetts, the company has developed a kerfless method that significantly reduces the costs associated with producing silicon wafers while increasing the efficiency of solar panels. This innovative process eliminates the need for wire-sawing large silicon ingots and utilizes less energy-intensive furnaces, resulting in higher efficiency solar cells and reduced carbon emissions. By offering a solution that integrates seamlessly into existing manufacturing processes, Leading Edge Equipment Technologies enables solar cell and panel manufacturers to enhance their products' power output without requiring substantial changes to their operations. The company, which rebranded from Leading Edge Crystal Technologies in May 2020, continues to advance technologies that support the growth of sustainable energy solutions.
NutriLeads
Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Phynova
Venture Round in 2020
Phynova Group Limited is a British life science company headquartered in Long Hanborough, UK, specializing in the development and commercialization of natural healthcare products derived from active compounds found in plants, particularly those used in traditional Chinese medicine. Founded in 2002, Phynova focuses on creating novel drug candidates and over-the-counter products targeting various health issues, including gastroenterology, anti-infective conditions, metabolic disorders, and consumer healthcare. The company's pharmaceutical pipeline features several clinical candidates, such as Melokinex for postoperative ileus and PYN17 for chronic hepatitis C, along with developmental projects aimed at obesity, type-2 diabetes, and acne. Additionally, Phynova offers functional ingredients and OTC products like PhynoRadiance for cosmetic applications and FatigFix, designed to reduce fatigue. With a commitment to addressing global health concerns, Phynova leverages its expertise in traditional medicine to deliver innovative solutions for modern healthcare challenges.
Panaceutics Nutrition
Series A in 2020
Panaceutics Nutrition is a company that specializes in the formulation, manufacturing, and distribution of customized nutritional products. Founded in 2018 by Edison Hudson and Staton Noel, it is based in Ringgold, Virginia. The company employs proprietary robotic technology to create individually tailored smoothies and nutritional supplements, which can be based on genetic and medical evaluations, as well as personal preferences. Panaceutics Nutrition focuses on mass customization, offering solutions that combine various nutritional supplements into convenient, easy-to-consume forms such as flavored gels and purees. By serving healthcare systems, pharmaceutical companies, and nutritional product manufacturers, the company aims to provide accessible and personalized nutrition to meet diverse consumer needs.
Inkbit
Venture Round in 2019
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.
Voxel8 Inc. is a Somerville, Massachusetts-based company that specializes in designing and manufacturing advanced electronic devices and digital 3D printing technologies. Incorporated in 2013, Voxel8 offers desktop 3D printers that utilize thermoplastics and UV resins, enabling the rapid fabrication of customizable electronic devices. The company's proprietary Project Wire software facilitates the design of 3D printable electronics, streamlining the production process. Voxel8's unique technology is particularly applicable in textile applications, allowing for the zonal tuning of mechanical properties and the enhancement of aesthetic features in products such as footwear, apparel, and medical devices. This additive manufacturing approach minimizes waste and supports sustainability through the use of bio-based materials. Voxel8's innovations enable customization of individual prints, enhancing performance characteristics like abrasion resistance, cushioning, and grip, while also incorporating full-color graphics and 3D embellishments. The technology was developed in collaboration with Professor Jennifer Lewis at Harvard University, positioning Voxel8 at the forefront of digital manufacturing in the textile and electronic sectors.
Additive Manufacturing Technologies
Series A in 2019
Additive Manufacturing Technologies (AMT) specializes in automated post-processing technology aimed at enhancing the efficiency of additive manufacturing. The company's flagship platform, PostPro, significantly improves cost, quality, safety, and throughput in the production of 3D printed parts. By automating the manual and often expensive steps traditionally associated with legacy additive manufacturing, AMT enables facilities to scale up to high-volume production lines. Their innovative digital technology and comprehensive suite of post-production hardware facilitate the processing of 3D-printed polymer parts, allowing clients to reduce lead times and manufacturing costs effectively.
Chinova Bioworks
Seed Round in 2019
Chinova Bioworks Inc. is a Canadian company established in 2016, specializing in the development of natural antimicrobials for the beverage industry. Based in Fredericton, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This innovative antimicrobial offers broad-spectrum protection against spoilage, effectively enhancing the shelf life of fresh juices and other products. Chinova's preservative is recognized for being a natural and healthy ingredient, making it suitable for use not only in foods and beverages but also in cosmetics and personal care items. By providing solutions that improve quality and freshness while reducing food waste, Chinova Bioworks aims to increase consumer satisfaction and support manufacturers in their efforts to deliver premium products.
ZeaVision
Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.
Panaceutics Nutrition
Venture Round in 2019
Panaceutics Nutrition is a company that specializes in the formulation, manufacturing, and distribution of customized nutritional products. Founded in 2018 by Edison Hudson and Staton Noel, it is based in Ringgold, Virginia. The company employs proprietary robotic technology to create individually tailored smoothies and nutritional supplements, which can be based on genetic and medical evaluations, as well as personal preferences. Panaceutics Nutrition focuses on mass customization, offering solutions that combine various nutritional supplements into convenient, easy-to-consume forms such as flavored gels and purees. By serving healthcare systems, pharmaceutical companies, and nutritional product manufacturers, the company aims to provide accessible and personalized nutrition to meet diverse consumer needs.
Hyalex Orthopaedics
Series A in 2019
Hyalex Orthopaedics, Inc. is a medical device company based in Lexington, Massachusetts, focused on developing and commercializing innovative products utilizing its proprietary HYALEX technology. This synthetic polymer is specifically designed to mimic the properties of natural cartilage, offering a unique advantage in maintaining low friction and wear under the high loads typically encountered in human joints. The company's goal is to provide solutions for diseased and damaged joints by enabling the replacement of arthritic cartilage while preserving healthy bone. Currently, Hyalex Orthopaedics' products remain in the development stage and have yet to receive regulatory approval for human use.
Adaptive3D
Series A in 2019
Adaptive3D is a leading supplier of premium additive manufacturing polymer resins focused on enabling high-volume production through optimized materials. The company specializes in a range of offerings, including rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers. By leveraging pioneering technologies, Adaptive3D provides high-quality polymer resins and specialty polymers that empower clients to create functional end-use products and prototypes with precise internal geometries. Their innovative solutions facilitate the production of differentiated products and enhance part performance, positioning Adaptive3D as a key player in the additive manufacturing industry.
Raycatch Ltd. is an Israeli company that specializes in automated diagnostics for solar energy assets through its AI-driven platform, DeepSolar. By leveraging existing solar data, Raycatch aims to revolutionize the photovoltaic (PV) market by transforming the management of solar operations and maintenance tasks from traditional manual processes to automated, on-demand solutions. The platform provides in-depth performance mapping and diagnostics of PV portfolios, focusing on various factors including equipment efficiency, maintenance needs, and potential issues such as disconnected cables and temperature variations. This comprehensive analysis allows solar asset owners to maximize energy yields, minimize operational costs, and improve overall asset profitability, all without the need for hardware installation or site visits. Raycatch's innovations enhance the efficiency of solar energy management and support the broader adoption of renewable energy technologies globally.
Miach Orthopaedics
Series A in 2018
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, specializing in the development of bio-engineered surgical implants aimed at promoting new tissue growth and aiding in connective tissue repair. Founded in 2016, the company focuses on its innovative Bridge-Enhanced ACL Repair technology, which serves as an alternative to traditional anterior cruciate ligament (ACL) reconstruction. This technology provides surgeons with a method to restore the normal anatomy and function of the knee for patients who have experienced ACL injuries, offering a promising option for recovery and rehabilitation.
Novum Medical
Series C in 2018
Novum Medical is a developer of innovative orthopedic implants, specializing in resorbable ortho-biomaterials designed for musculoskeletal surgery. The company focuses on creating products that utilize bioactive glass, which possesses porous, load-bearing, and osteoconductive properties. These advanced materials enhance the interface between the implant and bone, promoting a more natural healing process and improving overall performance. Novum Medical's technologies aim to enable surgeons to reconstruct bony anatomy effectively, addressing the clinical limitations associated with existing options in the market. The company's research and development efforts have broad applications within the musculoskeletal system.
Chinova Bioworks
Seed Round in 2018
Chinova Bioworks Inc. is a Canadian company established in 2016, specializing in the development of natural antimicrobials for the beverage industry. Based in Fredericton, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This innovative antimicrobial offers broad-spectrum protection against spoilage, effectively enhancing the shelf life of fresh juices and other products. Chinova's preservative is recognized for being a natural and healthy ingredient, making it suitable for use not only in foods and beverages but also in cosmetics and personal care items. By providing solutions that improve quality and freshness while reducing food waste, Chinova Bioworks aims to increase consumer satisfaction and support manufacturers in their efforts to deliver premium products.
Chromatic 3D Materials
Series A in 2018
Chromatic 3D Materials specializes in the development of advanced 3D printing materials, particularly focusing on durable elastomers suitable for finished manufactured goods. The company offers a unique additive manufacturing platform that utilizes reactive extrusion technology, enabling the production of industrial-strength rubber parts. Their innovative polyurethanes can withstand a range of mechanical stresses, such as flexing, stretching, twisting, and squeezing, making them highly adaptable and resilient. By providing customizable properties, Chromatic 3D Materials enables manufacturers to explore novel product designs while promoting sustainability and flexibility in material applications.
Tespo manufactures a liquid vitamin dispenser helping individuals with health goals. The company's system provides all the storage, convenience, and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives, or unnecessary ingredients.
Leading Edge Equipment Technologies
Seed Round in 2017
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of advanced equipment for solar panel production, specializing in single-crystal silicon wafers. Established in 2008 and based in Wilmington, Massachusetts, the company has developed a kerfless method that significantly reduces the costs associated with producing silicon wafers while increasing the efficiency of solar panels. This innovative process eliminates the need for wire-sawing large silicon ingots and utilizes less energy-intensive furnaces, resulting in higher efficiency solar cells and reduced carbon emissions. By offering a solution that integrates seamlessly into existing manufacturing processes, Leading Edge Equipment Technologies enables solar cell and panel manufacturers to enhance their products' power output without requiring substantial changes to their operations. The company, which rebranded from Leading Edge Crystal Technologies in May 2020, continues to advance technologies that support the growth of sustainable energy solutions.
ATRO Medical
Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.
NutriLeads
Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
QD Solar Inc., founded in 2014 and based in Toronto, Canada, is a company that develops advanced photovoltaic cells using colloidal quantum dot technology. The company's innovative approach combines efficient silicon solar cells with infrared solar cells in a hybrid architecture to capture more of the solar spectrum than traditional silicon cells alone. This technology aims to enhance the performance of solar cells, making them more cost-effective and efficient. QD Solar was spun off from the University of Toronto and focuses on creating new nanomaterial semiconductors to promote sustainable development and increase the use of renewable energy sources.
WattGlass
Series A in 2017
WattGlass LLC, established in 2014 and headquartered in Fayetteville, Arkansas, specializes in developing water-based anti-reflective coatings for glass and other transparent materials. The company's proprietary nanoparticle coating technology significantly reduces reflection, glare, and fogging, catering to diverse applications such as automotive, consumer goods, architectural glass, and solar photovoltaic industries. WattGlass' innovative solutions aim to replace hazardous materials commonly used in these sectors, offering an environmentally friendly alternative with improved durability and shelf life.
Essential Medical
Series B in 2016
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.
Blue Prairie
Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.
Arecor
Venture Round in 2016
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.
NOMADD Desert Solar Solutions
Series A in 2016
NOMADD Desert Solar Solutions specializes in innovative cleaning solutions for solar panels, particularly in desert environments. Headquartered in Saudi Arabia, the company has developed the NOMADD, a no-water mechanical automated dusting device designed to effectively clean solar panels in challenging, dusty conditions. This advanced system allows for the maintenance of solar installations in arid climates without the use of water, thereby preventing damage to the panels while ensuring optimal performance. The NOMADD device was initially developed at the King Abdullah University for Science and Technology, reflecting a strong foundation in research and innovation. Through its unique approach, NOMADD addresses the specific cleaning challenges posed by desert environments, making it a vital player in the solar energy sector.
NutriLeads
Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Natreon
Venture Round in 2015
Natreon, Inc. is a New Jersey-based company specializing in the development and marketing of Ayurvedic products. Founded in 1998, it operates a state-of-the-art research and development facility in Kolkata, India. Natreon focuses on creating dietary supplements derived from traditional Ayurvedic ingredients, with products such as CAPROS, an all-natural antioxidant for cardiovascular health; SENSORIL, an Ashwagandha formulation aimed at reducing stress and enhancing cognition; AYUFLEX, designed for joint health; and PRIMAVIE, a mitochondrial energy booster. The company emphasizes rigorous research and has established multiple clinical and safety studies to support its product efficacy. Natreon holds patents for its offerings in the United States and internationally, reinforcing its commitment to high standards and innovation in the wellness sector.
NovoPolymers
Venture Round in 2015
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.
Interface Biologics
Series B in 2015
Interface Biologics, Inc. is a commercial stage company based in Toronto, Canada, specializing in the development of advanced biomedical polymer technology aimed at enhancing the safety and efficacy of medical devices. Founded in 2001, the company has created patent-protected technologies, including anti-thrombogenic additives that are integrated into blood-contacting medical devices and polymer-enabled combination drug delivery systems. Interface Biologics holds exclusive licensing agreements for its Endexo™ technology with AngioDynamics and Fresenius Medical Care, which have led to FDA-cleared products such as the BioFlo PICCS, Ports, and DuraMax Dialysis Catheter. Additionally, the company has partnered with Qualimed to develop a drug-coated balloon utilizing its Kinesyx™ technology. The innovations provided by Interface Biologics have been clinically proven to minimize infection and thrombus-related complications, making significant contributions to various medical specialties, particularly ophthalmology.
EyePromise
Venture Round in 2014
EyePromise is a manufacturer of dietary supplements focused on promoting ocular health and addressing age-related vision loss. The company specializes in zeaxanthin supplements, aimed at individuals at risk of developing age-related macular degeneration. Its product line includes EyePromise Restore, a professional dietary supplement designed to support vision health, and EyePromise Ten, tailored for those specifically seeking zeaxanthin. Additionally, EyePromise offers the QuantifEYE program, which assesses the risk of developing age-related macular degeneration. Through its range of nutritional supplements, EyePromise aims to enhance visual performance, relieve dry eyes, and provide foundational nutrition for eye health.
Verdezyne
Venture Round in 2014
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.
Isobionics
Venture Round in 2014
Isobionics is a biotechnology company specializing in the production of natural aroma ingredients for various markets, including food, beverage, flavor, and fragrance. Utilizing a proprietary fermentation process, Isobionics focuses on isoprenoid-based products, such as nootkatone and valencene, which are essential for creating high-quality flavors and fragrances. This innovative approach ensures that the ingredients are free from pesticides and seasonal variability, resulting in products that are both purer and more cost-effective. By delivering superior sensory experiences, Isobionics aims to meet the evolving needs of its customers across the food, beverage, oral care, and personal care industries.
ChromaDex Corporation is a global nutraceutical company based in Los Angeles, California, focused on promoting healthy aging through innovative ingredient technologies. The company is best known for its flagship product, Nicotinamide riboside (NIAGEN), a patented form of vitamin B3 that enhances nicotinamide adenine dinucleotide (NAD+) levels, which naturally decline with age. In addition to NIAGEN, ChromaDex offers Immulina, a spirulina extract designed to improve immune function. The company operates through three main segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the majority of its revenue generated from the Consumer Products segment. ChromaDex markets its products directly in the United States and Canada, while also utilizing international distributors, and employs in-house expertise in chemistry, regulatory affairs, and safety consulting to develop commercially viable ingredients across various industries, including dietary supplements, food, beverage, skin care, and pharmaceuticals.
Arecor
Venture Round in 2013
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, specializing in the development, production, and commercialization of renewable polymers. Founded in 2006, Segetis focuses on a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry materials. The company's innovative technology supports the production of a range of industrial bioproducts such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, catering to specialty chemical applications. Segetis's chemistries create opportunities for product enablement and synergies across various industries, including those involved in the processing of starch, sugar crops, wood, cellulose, and paper pulp, as well as the chemical processing of vegetable oils and the manufacturing of biodiesel and linear alpha-olefins.
Xolve
Funding Round in 2012
Xolve Inc., established in 2008 and headquartered in Middleton, Wisconsin, specializes in the production and supply of graphene for industrial applications. The company offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene, which enhance properties such as modulus, electrical conductivity, thermal conductivity, barrier properties, and flame retardancy in various plastics used across automotive, aerospace, electronics, and other sectors. Xolve's unique processing technology enables effective, simple, room-temperature production of graphene composites. As of 2016, the company operates as a subsidiary of Reliance Industries Limited.
Regentis Biomaterials
Series C in 2012
Regentis Biomaterials Ltd. is a company specializing in tissue repair, particularly in the development and commercialization of biodegradable hydrogels for repairing damaged cartilage tissue. Founded in 2004 and based in Or-Akiva, Israel, with an additional office in Princeton, New Jersey, the company’s core technology includes Gelrin, a hydrogel matrix composed of polyethylene glycol diacrylate and denatured fibrinogen. This innovative platform merges the stability of synthetic materials with the bio-functionality of natural substances, catering to various clinical applications. Regentis's flagship product, GelrinC, is designed for treating articular cartilage lesions and is currently undergoing clinical trials. The company’s focus is on orthopedic treatments, aiming to restore health and improve the quality of life for patients suffering from cartilage damage and related conditions.
Verdezyne
Venture Round in 2011
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.
CellMade
Funding Round in 2010
CellMade SAS is a biopharmaceutical company based in Chappes, France, with additional facilities in Marseille and Ruffieux. Founded in 2007, the company specializes in developing and supplying a range of cell biology products, including human-origin primary cells and various types of specialized cells such as blood cells, endothelial cells, and pancreatic cells. CellMade also offers laboratory services that encompass biobanking, cell-based assays, cytometry, and mass spectrometry. The company invests in its research and development initiatives through its CellInsight platform, which focuses on identifying targets and biomarkers associated with inflammatory pathologies. By providing customized cell isolation and co-culture models, CellMade aims to advance the field of cell biology and support various research applications.
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, specializing in the development, production, and commercialization of renewable polymers. Founded in 2006, Segetis focuses on a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry materials. The company's innovative technology supports the production of a range of industrial bioproducts such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, catering to specialty chemical applications. Segetis's chemistries create opportunities for product enablement and synergies across various industries, including those involved in the processing of starch, sugar crops, wood, cellulose, and paper pulp, as well as the chemical processing of vegetable oils and the manufacturing of biodiesel and linear alpha-olefins.
Novomer is a materials company based in Waltham, Massachusetts, founded in 2004. The company specializes in developing high-performance green plastics, polymers, and other chemicals using proprietary catalytic technology. This technology enables the cost-effective transformation of carbon dioxide and other renewable materials into various industrial products. By combining traditional chemical feedstocks with carbon dioxide or carbon monoxide, Novomer aims to create sustainable chemicals and materials for diverse applications, contributing to efforts in mitigating global warming and climate change.
Viocare
Venture Round in 2009
Viocare Inc., a privately-held company, specializes in developing innovative web and mobile solutions that combine advanced nutrition science and behavior change strategies. Its cloud-based platform offers assessment tools for academic research and clinical use, analyzing dietary behaviors to generate personalized lifestyle plans. Viocare's software facilitates remote or face-to-face nutritional counseling, driving sustainable behavior changes and enabling healthcare professionals to integrate affordable, effective nutritional care into their patient services.
Provexis plc is a UK-based company that specializes in the development, licensing, and marketing of functional foods, medical foods, and dietary supplements on a global scale. Founded in 1999 and headquartered in Reading, Provexis is known for its flagship product, Fruitflow, a tomato extract that helps reduce the risk of abnormal blood clotting associated with cardiovascular diseases, including heart attacks and strokes. Fruitflow is available in syrup and powder forms, which can be incorporated into various food, beverage, and dietary supplement products. Additionally, Provexis offers Fruitflow + Omega-3, a capsule supplement that promotes healthy blood flow and supports normal heart function. The company has a collaboration agreement with By-Health Co., Ltd. and distributes its products through retail outlets and online platforms.
Ganeden Biotech
Venture Round in 2007
Ganeden, Inc. is a biotechnology company based in Mayfield Heights, Ohio, that specializes in the manufacture and supply of probiotics and probiotic bacteria. Founded in 1997, the company focuses on developing advanced strains of probiotics that address limitations associated with traditional strains. Ganeden licenses its probiotic technology for use in a variety of applications, including functional food and beverages, dietary supplements, and personal care products. Key offerings include GanedenBacillus coagulans for food and beverage applications, Bonicel for anti-aging cosmetics, and Staimune, an immune health solution. The company has also established a strategic alliance with Sensus America. With a commitment to improving quality of life, Ganeden has successfully introduced a range of consumer products, selling nearly 200 million doses across over 40,000 retail outlets since its product launch in 2003. As of 2017, Ganeden operates as a subsidiary of Kerry Group plc.
Food Quality Sensor International
Series B in 2007
Food Quality Sensor International, Inc. is a sensor technology company based in Lexington, Massachusetts, that specializes in real-time and interactive devices for measuring food freshness. Founded in 2004, the company offers innovative products such as SensorQ, which assesses the freshness of meat and poultry within their packaging, and SensorfreshQ, a handheld electronic nose designed to detect spoilage in these products. Its solutions cater to various sectors including food processing, grocery distribution, food service, regulatory bodies, defense, and consumer retail markets, aiming to enhance food safety and quality across the supply chain.
Harland Medical Systems
Private Equity Round in 2007
Harland Medical Systems, Inc. specializes in providing surface enhancement products for the healthcare sector, focusing on medical device coatings and surface modification materials. Founded in 2002 and based in Eden Prairie, Minnesota, the company offers a range of services that include antimicrobial coatings, method development for coating applications, and friction testing equipment to assess the performance of lubricious coatings on devices such as catheters and guide wires. Harland Medical Systems caters to a diverse clientele across various clinical markets, including neurology, urology, cardiology, wound care, and endoscopy. The company's integrated solutions aim to enhance the value of healthcare products, improve patient outcomes, and optimize the economic efficiencies of medical procedures.
Micromuscle
Venture Round in 2006
Micromuscle AB, established in 2000, specializes in the development of innovative biomedical products utilizing its proprietary electroactive polymer technology known as MICROMUSCLE. This technology enables electroactive polymers to expand and contract in response to an electric potential, making it particularly suitable for various vascular applications. By focusing on the unique properties of these materials, Micromuscle aims to advance the field of biomedical engineering through the creation of effective and efficient solutions.
IntegraGen
Venture Round in 2006
IntegraGen is a French biotechnology company located in the Genopole life science park in Evry, near Paris. The company specializes in the development of genetic biomarkers and leverages its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotechnology firms, and research organizations. IntegraGen offers a range of services, including clinical research, bioinformatics, and bioanalysis, as well as solutions for agrigenomics and microbiologic research. With its unique intellectual property and access to extensive sample libraries, IntegraGen aims to advance the understanding and treatment of central nervous system and metabolic diseases.
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
ORYXE Energy International
Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Morphotek
Series C in 2004
Morphotek, established in 2000, is a prominent life science company specializing in developing novel biological products to combat cancer, inflammation, and infectious diseases. The company's core technology, morphogenics, was co-invented by its current President and CEO, Dr. Nicholas Nicolaides, during his postgraduate research at Johns Hopkins Medical School. Morphotek focuses on discovering and developing monoclonal antibodies (mAbs) using this proprietary technology to treat various conditions such as ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The company conducts independent research and clinical development programs for its drug candidates.
Optiva develops and manufactures nanomaterials for use in optical, electro-optical, and semiconductor applications.
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.